{"id":"preservative-free-parenteral-treprostinil","safety":{"commonSideEffects":[{"rate":"20-40%","effect":"Headache"},{"rate":"10-30%","effect":"Nausea"},{"rate":"10-25%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"By binding to and activating prostacyclin receptors, treprostinil promotes vasodilation and reduces pulmonary arterial pressure, thereby improving symptoms and outcomes in patients with pulmonary arterial hypertension.","oneSentence":"Treprostinil mimics the action of prostacyclin, which is a natural substance that dilates blood vessels and prevents platelet aggregation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:58.029Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pulmonary arterial hypertension (PAH)"}]},"trialDetails":[{"nctId":"NCT06350032","phase":"PHASE3","title":"Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH","status":"RECRUITING","sponsor":"AOP Orphan Pharmaceuticals AG","startDate":"2024-07-31","conditions":"Pulmonary Arterial Hypertension","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"preservative-free parenteral treprostinil","genericName":"preservative-free parenteral treprostinil","companyName":"AOP Orphan Pharmaceuticals AG","companyId":"aop-orphan-pharmaceuticals-ag","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Treprostinil mimics the action of prostacyclin, which is a natural substance that dilates blood vessels and prevents platelet aggregation. Used for Pulmonary arterial hypertension (PAH).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}